This inventor holds 5 USPTO granted patents. Top assignees: Institut De Recherches Chimiques Et Biologiques Appliquees (i.r.c.e.b.a.), Institut De Ercherches Chimiques Et Biologiques Appliquees (i.r.c.e.b.a.), Societe a Responsabilite Limitee: Institut De Recherches Chimiques Et. Active years: 1987-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Celle St Cloud, FR (1987)
- Saint-nom-la-Breteche, FR (1989)
- La Celle-Saint-Cloud, FR (1989 - 1990)
- St. Nom la Breteche, FR (1994)
Company Filing History:
3 out of 6 
1 out of 1 
1 out of 1 Years Active: 1987-1994
Title: Jean-Yves Lacolle: Innovations that Revolutionize Industries
Introduction:
Jean-Yves Lacolle, a prolific inventor, has made significant contributions to various industries with his groundbreaking innovations. His dedication to practicality and efficiency is evident in his numerous patents, which have not only transformed industries but also improved the lives of people worldwide. This article explores Lacolle's latest patents, highlights of his career, notable collaborations, and the lasting impact of his inventions.
Latest Patents:
Lacolle's latest patents include the development of 4-methylthiazole derivatives and oxyimino derivatives of thiazole. These novel industrial products have paved the way for advancements in various fields. Specifically, the oxyimino derivatives of thiazole, including E and Z diastereoisomers, have shown potential as anticonvulsants, offering new possibilities for therapy.
Career Highlights:
Throughout his career, Lacolle has achieved remarkable milestones, positioning himself as a pioneer in innovation. He has been associated with renowned research organizations, notably the Institut de Recherches Chimiques et Biologiques Appliquées (IRCEBA). Lacolle's expertise and creativity have been instrumental in driving breakthroughs in chemistry and biotechnology.
Collaborations:
Lacolle has collaborated with esteemed individuals in his scientific journey. Notable coworkers include Bernard Danree and Patrick Houziaux, whose combined knowledge and expertise have synergistically contributed to the success of their projects. Collaborations with likeminded innovators have enhanced Lacolle's ability to develop practical and impactful inventions.
Conclusion:
Jean-Yves Lacolle's commitment to innovation and practicality has made him a distinguished figure in the world of patents and inventions. His latest patents, 4-methylthiazole derivatives, and oxyimino derivatives of thiazole, represent significant advancements in their respective fields. Lacolle's career highlights, including his association with esteemed research organizations and collaborations with talented individuals, demonstrate his enduring impact on the industry. We eagerly anticipate further contributions from this exceptional innovator as he continues to shape the future through his groundbreaking inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile